Panikstörung und Agoraphobie

• Literatur

• 1 Weissman MM, Bland RC, Canino GJ. et al. The cross-national epidemiology of panic disorder. Archs Gen Psychiatry 1997; 54: 305-309
• 2 Wittchen HU, Jacobi F. Die Versorgungssituation psychischer Störungen in Deutschland. Eine klinisch-epidemiologische Abschätzung anhand des Bundes-Gesundheitssurveys 1998. Bundesgesundheitsblatt – Gesundheitsforschung – Gesundheitsschutz 2001; 44: 993-1000
• 3 Jacobi F, Hofler M, Siegert J. et al. Twelve-month prevalence, comorbidity and correlates of mental disorders in Germany: the Mental Health Module of the German Health Interview and Examination Survey for Adults (DEGS1-MH). Int J Methods Psychiatr Res 2014; 23: 304-319
• 4 Somers JM, Goldner EM, Waraich P. et al. Prevalence and incidence studies of anxiety disorders: a systematic review of the literature. Can J Psychiatry 2006; 51: 100-113
• 5 In-Albon T, Margraf J. Panik und Agoraphobie. In: Wittchen HU, Hoyer J. Hrsg. Klinische Psychologie und Psychotherapie. Berlin, Heidelberg: Springer Verlag; 2011
• 6 Bandelow B, Wiltink J, Alpers GW. et al. Deutsche S3-Leitlinie Behandlung von Angststörungen. Zugriff am 28. Januar 2016 unter: https://www.dgppn.de/fileadmin/user_upload/_medien/download/pdf/kurzversion-leitlinien/S3-LL_Lang_Angststörungen_2014.pdf
• 7 National Institute for Health and Clinical Excellence (NICE). Anxiety: Management of anxiety (panic diorder with or without agoraphobia and generalized anxiety disorder) in adults in primary, secondary and community care. 2011
• 8 Dilling H, Mombour W, Schmidt MH. Internationale Klassifikation psychischer Störungen ICD-10 Kapitel V (F). Klinisch-diagnostische Leitlinien. Bern: Hans Huber Verlag; 2008
• 9 Asmundson GJ, Taylor S, Smits JA. Panic disorder and agoraphobia: an overview and commentary on DSM-5 changes. Depress Anxiety 2014; 31: 480-486
• 10 Klein DF. Anxiety reconceptualized. Compr Psychiatry 1980; 21: 411-427
• 11 Wittchen H-U, Gloster AT, Beesdo-Baum K. et al. Agoraphobia: A review of the diagnostic classificatory position and criteria. Depress Anxiety 2010; 27: 113-133
• 12 Locke AB, Kirst N, Shultz CG. Diagnosis and management of generalized anxiety disorder and panic disorder in adults. Am Fam Physician 2015; 91: 617-624
• 13 Batterham PJ, Mackinnon AJ, Christensen H. The panic disorder screener (PADIS): Development of an accurate and brief population screening tool. Psychiatry Res 2015; 228: 72-76
• 14 Oromendia P, Bonillo A, Molinuevo B. Web-based screening for Panic Disorder: Validity of a single-item instrument. J Affect Disord 2015; 180: 138-141
• 15 Bandelow B. Panic and agoraphobia scale (PAS). Göttingen, Bern, Toronto, Seattle: Hogrefe & Huber Publishers; 1999
• 16 Shear MK, Brown TA, Barlow DH. et al. Multicenter collaborative panic disorder severity scale. Am J Psychiatry 1997; 154: 1571-1575
• 17 Chambless DL, Caputo GC, Bright P. et al. Assessment of fear of fear in agoraphobics: the body sensations questionnaire and the agoraphobic cognitions questionnaire. J Consult Clin Psychol 1984; 52: 1090-1097
• 18 Ehlers A, Margraf J. Fragebogen zu körperbezogenen Ängsten, Kognitionen und Vermeidung (AKV). Manual. 2. Aufl.. Göttingen: Beltz Test GmbH; 2001
• 19 Ehlers A, Margraf J, Chambless DL. Fragebogen zu körperbezogenen Ängsten, Kognitionen und Vermeidung (AKV). 2.. Aufl. Weinheim: Beltz Test Gesellschaft; 2001
• 20 Kessler RC, Chiu WT, Jin R. et al. The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2006; 63: 415-424
• 21 Wittchen U, Jacobi F, Rehm J. et al. The size and burden of mental disorders and other disorders in brain in Europe 2010. Eur Neuropsychopharmacol 2011; 21: 655-679
• 22 Goodwin RD, Faravelli C, Rosi S. et al. The epidemiology of panic disorder and agoraphobia in Europe. Eur Neuropsychopharmacol 2005; 15: 435-443
• 23 Angst J, Gamma A, Baldwin DS. et al. The generalized anxiety spectrum: prevalence, onset, course and outcome. Eur Arch Psychiatry Clin Neurosci 2009; 259: 37-45
• 24 Wittchen HU, Reed V, Kessler RC. The relationship of agoraphobia and panic in a community sample of adolescents and young adults. Arch Gen Psychiatry 1998; 55: 1017-1024
• 25 Reed V, Wittchen HU. DSM-IV panic attacks and panic disorder in a community sample of adolescents and young adults: how specific are panic attacks?. J Psychiatr Res 1998; 32: 335-345
• 26 Altinbas G, Altinbas K, Guloksuz SA. et al. Temperament characteristics in patients with panic disorder and their first-degree relatives. Compr Psychiatry 2015; 60: 73-77
• 27 Bruce SE, Yonkers KA, Otto MW. et al. Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study. Am J Psychiatry 2005; 162: 1179-1187
• 28 Wittchen HU. Der Langzeitverlauf unbehandelter Angststörungen: Wie häufig sind Spontanremissionen? [The long-term course of untreated anxiety disorders: What is the frequency of spontaneous remission?]. Verhaltenstherapie 1991; 1: 273-282
• 29 Craske MG, Simos G. Panic disorder and agoraphobia. In: Simos G, Hofmann SG. Hrsg. CBT in anxiety disorders: A practitioner book. New York: John Wiley & Sons; 2013
• 30 Keller MB, Yonkers KA, Warshaw MG. et al. Remission and relapse in subjects with panic disorder and agoraphobia: A prospective short interval naturalistic follow-up. J Nerv Ment Dis 1994; 182: 290-296
• 31 Lim SW, Ko EM, Shin DW. et al. Clinical symptoms associated with suicidality in patients with panic disorder. Psychopathology 2015; 48: 137-144
• 32 Brown TA, Campbell LA, Lehman CL. et al. Current and lifetime comorbidity of the DSM-IV anxiety and mood disorders in a large clinical sample. J Abnormal Psychology 2001; 110: 585
• 33 Sareen J, Jacobi F, Cox BJ. et al. Disability and poor quality of life associated with comorbid anxiety disorders and physical conditions. Arch Intern Med 2006; 166: 2109-2116
• 34 Margraf J, Schneider S. Lehrbuch der Verhaltenstherapie. Berlin: Springer Verlag; 2008
• 35 Ruhmland M, Margraf J. Effektivität psychologischer Therapien von Panik und Agoraphobie: Meta-Analysen auf Störungsebene. Verhaltenstherapie 2001; 11: 41-53
• 36 Foa EB, McNally RJ. Mechanisms of change in exposure therapy. In: Rapee M. Hrsg. Current controversies in the anxiety disorders. New York: Guilford Press; 1996: 329-343
• 37 Foa EB, Kozak MJ. Emotional processing of fear: exposure to corrective information. Psychol Bull 1986; 99: 20-35
• 38 Craske M. Optimizing exposure therapy for anxiety disorders: An inhibitory learning and inhibitory regulation approach. Verhaltenstherapie 2015; 25: 134-143
• 39 Bouton ME. Context, time, and memory retrieval in the interference paradigms of Pavlovian learning. Psychol Bull 1993; 114: 80-99
• 40 Vlachos I, Herry C, Luthi A. et al. Context-dependent encoding of fear and extinction memories in a large-scale network model of the basal amygdala. PLoS Comput Biol 2011; 7: e1001104
• 41 Lissek S, Rabin SJ, McDowell DJ. et al. Impaired discriminative fear-conditioning resulting from elevated fear responding to learned safety cues among individuals with panic disorder. Behav Res Ther 2009; 47: 111-118
• 42 Tabibnia G, Lieberman MD, Craske M. The lasting effects of words on feelings: Words may facilitate exposure effects to threatening images. Emotion 2008; 8: 307-317
• 43 Sanchez-Meca J, Rosa-Alcazar A, Marin-Martinez F. et al. Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia: A meta-analysis. Clin Psychol Rev 2010; 30: 37-50
• 44 Mitte K. A meta-analysis of the efficacy of psycho-and pharmacotherapy in panic disorder with or without agoraphobia. J Affect Disord 2005; 88: 27-45
• 45 Bandelow B, Reitt M, Rover C. et al. Efficacy of treatments for anxiety disorders: a meta-analysis. Int Clin Psychopharmacol 2015; 30: 183-192
• 46 Huhn M, Tardy M, Spineli LM. et al. Efficacy of pharmacotherapy and psychotherapy for adult psychiatric disorders: a systematic overview of meta-analyses. JAMA Psychiatry 2014; 71: 706-715
• 47 Furukawa T, Watanabe N, Churchill R. Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobie (Review). The Cochrane Library 2009
• 48 Hofmann SG, Otto MW, Pollack MH. et al. D-cycloserine augmentation of cognitive behavioral therapy for anxiety disorders: an update. Curr Psychiatry Rep 2015; 17: 532